Clinical studies recruiting near Guilford

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine
Phase 3 · Kallyope Inc. · NCT07674654 EU Post-Market Registry to Collect Real-World Clinical Data on the Use of the Histolog Scanner.
Phase N/A · SamanTree Medical SA · NCT07006090 A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic
Phase 3 · AstraZeneca · NCT06868277 A Study to Evaluate Patient-Reported Satisfaction, Effectiveness, and Safety of Atezolizumab in Participants Treated in
Phase N/A · Hoffmann-La Roche · NCT07284121 Visugromab in Cachexia International Trial
Phase 2/Phase 3 · CatalYm GmbH · NCT07112196 Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM
Phase 2 · Smilow Cancer Hospital Care Center - Guilford · SWOG Cancer Research Network · NCT06769126 Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Phase 2/Phase 3 · Smilow Cancer Hospital Care Center - Guilford · NRG Oncology · NCT05174169 Insect vs Animal Protein for Building Muscle
NA · University of Surrey · NCT07159919 ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathol
Phase 3 · Smilow Cancer Hospital Care Center - Guilford · Alliance for Clinical Trials in Oncology · NCT06876714 A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancre
Phase 3 · Incyte Corporation · NCT07522073 The Remote Study: Investigating the Effects or Online Exercise on Quality of Life in Men With Prostate Cancer
NA · University of Surrey · NCT05989854 Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene M
Phase 2 · Smilow Cancer Hospital Care Center - Guilford · SWOG Cancer Research Network · NCT05806515 EUthyroid2: the Next Step Towards the Elimination of Iodine Deficiency and Preventable Iodine-related Disorders in Europ
NA · EUthyroid · NCT06769009 Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggress
Phase 2 · Smilow Cancer Hospital Care Center - Guilford · National Cancer Institute (NCI) · NCT06649812 An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)
Phase 3 · AstraZeneca · NCT05952557 An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.
Phase 3 · Novartis Pharmaceuticals · NCT05939414 Phase Ib/II Platform Study of Multiple Anti-Cancer Agents in Participants With Metastatic Prostate Cancer
Phase 1/Phase 2 · AstraZeneca · NCT07590934 Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carci
Phase 3 · Smilow Cancer Hospital Care Center - Guilford · National Cancer Institute (NCI) · NCT05256225 A Study to Investigate the Efficacy, Safety, and Tolerability of AZD4144in Participants With Sepsis-associated Acute Kid
Phase 2 · AstraZeneca · NCT07215702 Clinical and Immunogenetic Characterization of Giant Cell Arteritis (GCA) and Polymyalgia Rheumatica (PMR)
Phase N/A · University of Leeds · NCT04102930 A Study to Provide Continued Access to and Assess Long-Term Safety of the Study Drug(s)
Phase 3 · Daiichi Sankyo · NCT06174987 Developing ctDNA Guided Adjuvant Therapy for Gastrooesophageal Cancer
Phase 2 · University of Southampton · NCT05965479 Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
Phase 3 · Smilow Cancer Hospital Care Center - Guilford · ECOG-ACRIN Cancer Research Group · NCT04566328 De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Eq
Phase 3 · Smilow Cancer Hospital Care Center - Guilford · NRG Oncology · NCT04852887 LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have C
Phase 3 · Boehringer Ingelheim · NCT06632457 Will a Pre-therapy Exercise Intervention Improve the Outcomes of Patients With Advanced Oesophageal Cancer?
NA · University of Surrey · NCT07375420 The Next Step Towards the Elimination of Iodine Deficiency and Preventable Iodine-related Disorders in Europe
NA · EUthyroid · NCT06801691 Palliative Care and Oncology Survey on Terminology
Phase N/A · Our Lady's Hospice and Care Services · NCT05871996 Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide,
Phase 3 · Smilow Cancer Hospital Care Center - Guilford · National Cancer Institute (NCI) · NCT06058377 Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
Phase 3 · Nuvalent Inc. · NCT06765109

Look up another city

Look up another condition